![Eric Carter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 75 801 $ in data 31/07/2026
Eric G.
Carter currently serves as Non-Executive Director at AEON Biopharma Sub, Inc. since 2023, Director at Visgenx, Inc. since 2022, and Independent Director at AEON Biopharma, Inc. since 2023.
Former roles include Director at Bioniz Therapeutics, Inc. from 2016 to 2022, Independent Director at Adverum Biotechnologies, Inc. from 2017 to 2021, Chief Medical Officer & Senior Vice President at Allergan, Inc. from 2011 to 2015, Chief Scientific & Medical Officer at KP Pharmaceuticals LLC from 2009 to 2011, Vice President & Global Head at GSK Plc from 1999 to 2009, Chief Medical Officer at Lundbeck Seattle BioPharmaceuticals, Inc. from 2018 to 2019, Associate Professor at The University of North Carolina at Charlotte, and Chief Marketing Officer at IACTA Pharmaceuticals, Inc. Education includes a doctorate from the University of Cambridge, an undergraduate degree from the University of London, and doctorates from the University of Miami and The University of Miami Leonard M.
Miller School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 17/06/2026 | 258.705 ( 0,37% ) | 75 801 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AEON BIOPHARMA, INC. | Direttore/Membro del Consiglio | 01/06/2023 |
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales pharmaceuticals | Direttore/Membro del Consiglio | 24/07/2023 |
Visgenx, Inc.
 Visgenx, Inc. BiotechnologyHealth Technology Develops therapeutics to protect against the loss of sight from retinal disorders | Direttore/Membro del Consiglio | 01/01/2022 |
| Società | Posizione | Fine |
|---|---|---|
Bioniz Therapeutics, Inc.
 Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biotechnology company | Direttore/Membro del Consiglio | 01/02/2022 |
| ADVERUM BIOTECHNOLOGIES, INC. | Direttore/Membro del Consiglio | 12/05/2021 |
| ALDER BIOPHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 17/01/2019 |
| ALLERGAN, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2015 |
KP Pharmaceuticals LLC
 KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets and sells generic pharmaceutical products | Direttore Tecnico/Scientifico/R&S | 01/01/2011 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 15 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
KP Pharmaceuticals LLC
KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets and sells generic pharmaceutical products | Health Technology |
Bioniz Therapeutics, Inc.
Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biotechnology company | Commercial Services |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
The University of Miami Leonard M. Miller School of Medicine
 The University of Miami Leonard M. Miller School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales pharmaceuticals | Health Technology |
IACTA Pharmaceuticals, Inc.
 IACTA Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes eyecare products | Health Technology |
Visgenx, Inc.
Visgenx, Inc. BiotechnologyHealth Technology Develops therapeutics to protect against the loss of sight from retinal disorders | Health Technology |
AEON Biopharma, Inc.
 AEON Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for neurology and gastroenterology markets | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
